Silvercrest Asset Management’s Exagen XGN Stock Holding History

Silvercrest Asset Management’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.39M	Sell	514,761 -23,109	-4%	-$87K	0.02%	527
2026 Q1	$1.61M	Sell	537,870 -60,050	-10%	-$232K	0.01%	550
2025 Q4	$3.64M	Buy	597,920 +78,452	+15%	+$714K	0.03%	470
2025 Q3	$5.71M	Sell	519,468 -12,299	-2%	-$109K	0.04%	410
2025 Q2	$3.71M	Hold	531,767	–	–	0.02%	467
2025 Q1	$1.91M	Sell	531,767 -3,250	-0.6%	-$12.3K	0.01%	550
2024 Q4	$2.19M	Sell	535,017 -5,871	-1%	-$21.2K	0.01%	521
2024 Q3	$1.67M	Sell	540,888 -3,989	-0.7%	-$10.3K	0.01%	516
2024 Q2	$992K	Hold	544,877	–	–	0.01%	627
2024 Q1	$866K	Hold	544,877	–	–	0.01%	629
2023 Q4	$1.08M	Hold	544,877	–	–	0.01%	580
2023 Q3	$1.32M	Sell	544,877 -2,256	-0.4%	-$5.72K	0.01%	550
2023 Q2	$1.59M	Buy	547,133 +44,518	+9%	+$127K	0.01%	520
2023 Q1	$1.22M	Hold	502,615	–	–	0.01%	546
2022 Q4	$1.21M	Sell	502,615 -4,493	-0.9%	-$11.5K	0.01%	552
2022 Q3	$1.37M	Buy	507,108 +11,520	+2%	+$64.3K	0.01%	505
2022 Q2	$2.85M	Sell	495,588 -22,029	-4%	-$128K	0.02%	415
2022 Q1	$4.16M	Buy	517,617 +4,727	+0.9%	+$40.8K	0.03%	402
2021 Q4	$5.96M	Hold	512,890	–	–	0.04%	351
2021 Q3	$6.97M	Buy	512,890 +202,692	+65%	+$2.69M	0.05%	326
2021 Q2	$4.65M	Sell	310,198 -1,257	-0.4%	-$19.3K	0.03%	401
2021 Q1	$5.45M	Buy	+311,455	New	+$5.55M	0.04%	364

Other funds holding XGN

Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

NCNMGF

Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FCM

FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

MBAM

Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Silvercrest Asset Management's XGN Position: Q2 2026 in Review

Silvercrest Asset Management reduced its Exagen (XGN) stake by 4.3% in Q2 2026, selling an estimated $87K and leaving 514,761 shares worth $2.39M. The position accounts for 0.02% of the portfolio, ranked #527.

Silvercrest Asset Management first reported a position in XGN in Q1 2021 and has held it in 22 quarters since. The position peaked at $6.97M in Q3 2021. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

Silvercrest Asset Management held 514,761 shares of Exagen worth $2.39M as of Q2 2026.
Silvercrest Asset Management sold 23,109 Exagen shares in Q2 2026, an estimated $87K.
Exagen made up 0.02% of Silvercrest Asset Management's portfolio in Q2 2026, its #527 holding.
Silvercrest Asset Management first reported a position in Exagen in Q1 2021 and has held it in 22 quarters since.
Silvercrest Asset Management's Exagen position peaked at $6.97M in Q3 2021.
57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Silvercrest Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.